Ascendis Pharma A ASND
NASDAQ ASND
$228.07 -1.98 (-0.86%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Total Debt (2021 - 2026)

Updated

Ascendis Pharma A's Total Debt was $447.09 million in the quarter ended Jun 30, 2026, down 57.7% from $1.06 billion a year earlier and down 66.0% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Total Debt (2021 - 2026) Analysis & Trends

As of Dec 31, 2025, Total Debt at Ascendis Pharma A came in at $1.21 billion, up 14.8% from the prior year.

  • Total Debt has now increased for four consecutive years, with a four-year compound annual growth rate of 81.3% (years ended Dec 2021 to Dec 2025).
  • In earlier years, Total Debt was $1.05 billion in the year ended Dec 31, 2024 (+26.0%), $836.59 million in the year ended Dec 31, 2023 (+104.8%), $408.47 million in the year ended Dec 31, 2022 (+264.5%) and $112.07 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Debt since the quarter ended Dec 31, 2022.
  • Compared with a year earlier, Total Debt was higher in seven of the last eight quarters, with growth averaging 16.5%.
  • The best year-over-year quarter for Total Debt over five years was the quarter ended Dec 31, 2022 (growth of 252.8%); the worst was the quarter ended Jun 30, 2026 (a decline of 57.7%).
  • Per Business Quant data, ASND's Total Debt in the three quarters before the quarter ended Jun 30, 2026 was $1.32 billion (quarter ended Mar 31, 2026), $1.25 billion (quarter ended Dec 31, 2025) and $1.16 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Ascendis Pharma A 14.26 Bn 10.50 Bn 362.22 Mn 447.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 447.09 Mn
Mar 31, 2026 1.32 Bn
Dec 31, 2025 1.25 Bn
Sep 30, 2025 1.16 Bn
Jun 30, 2025 1.06 Bn
Mar 31, 2025 1.03 Bn
Dec 31, 2024 1.04 Bn
Sep 30, 2024 1.02 Bn
Jun 30, 2024 872.60 Mn
Mar 31, 2024 925.47 Mn
Dec 31, 2023 832.12 Mn
Sep 30, 2023 598.16 Mn
Jun 30, 2023 522.00 Mn
Mar 31, 2023 515.19 Mn
Dec 31, 2022 395.40 Mn
Sep 30, 2022 537.56 Mn
Jun 30, 2022 531.53 Mn
Mar 31, 2022 521.59 Mn
Dec 31, 2021 112.07 Mn
API Access

Ascendis Pharma A Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ASND&period=max&api_key=YOUR_API_KEY